Related Experiment Video
Updated: Jun 3, 2026
09:29
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Neuromyelitis optica and astrocytic damage in its pathogenesis.
1Department of Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine, 1-1 Seiryomachi, Aobaku, Sendai 980-8574, Japan. fujikazu@em.neurol.med.tohoku.ac.jp
Journal of the Neurological Sciences
|March 15, 2011
Summary
Neuromyelitis optica (NMO) is distinct from multiple sclerosis (MS) due to the presence of an aquaporin 4 (AQP4) antibody. This antibody targets astrocytes, causing severe neurological damage and clarifying diagnostic and treatment strategies for NMO.
Area of Science:
- Neuroimmunology
- Neurology
- Pathology
Background:
- Neuromyelitis optica (NMO) and multiple sclerosis (MS) share overlapping symptoms, leading to historical diagnostic challenges.
- The discovery of neuromyelitis optica-specific autoantibodies targeting aquaporin 4 (AQP4) has been pivotal in differentiating NMO from MS.
- Aquaporin 4 (AQP4) is a critical water channel protein predominantly found on astrocyte foot processes in the central nervous system.
Purpose of the Study:
- To elucidate the diagnostic and pathogenetic significance of aquaporin 4 (AQP4) antibodies in distinguishing Neuromyelitis Optica (NMO) from Multiple Sclerosis (MS).
- To highlight the role of AQP4 antibodies in guiding treatment strategies for NMO.
- To underscore the pathological differences between NMO and MS based on AQP4 and glial fibrillary acidic protein (GFAP) expression.
Main Methods:
- Clinical differentiation based on the presence or absence of NMO-specific autoantibodies against aquaporin 4 (AQP4).
- Pathological examination of acute lesions in NMO and MS, assessing immunoreactivity for AQP4, glial fibrillary acidic protein (GFAP), and myelin basic protein.
- Analysis of glial fibrillary acidic protein (GFAP) levels in cerebrospinal fluid during acute exacerbations of NMO and MS.
Main Results:
- The presence of aquaporin 4 (AQP4) antibodies clearly distinguishes Neuromyelitis Optica (NMO) from Multiple Sclerosis (MS).
- Pathology in NMO shows significant loss of AQP4 and GFAP immunoreactivity, with relative preservation of myelin basic protein, unlike in MS.
- Elevated GFAP levels in cerebrospinal fluid are characteristic of acute NMO exacerbations, but not MS.
Conclusions:
- Aquaporin 4 (AQP4) antibody status is a critical diagnostic marker for Neuromyelitis Optica (NMO), essential for determining appropriate treatment.
- Severe astrocytic damage mediated by AQP4 antibodies is the key pathological feature differentiating NMO from MS.
- Experimental studies confirm the pathogenic role of AQP4 antibodies in NMO, reinforcing their diagnostic and therapeutic implications.
Related Concept Videos
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:25Secondary Spinal Cord Injury llI: Pathophysiology
Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...